Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Dynamic differences between SUVmax and tumor to normal tissue ratio of 18F-BPA PET in radioresistant squamous cell head and neck cancer and soft tissue sarcoma

Takahiro Morita, Jun Hatazawa and Hiroaki Kurihara
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 491;
Takahiro Morita
1Department of Diagnostic Radiology National Cancer Center Hospital Chuo-ku Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
2Osaka University Graduate School of Medicine Suita, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroaki Kurihara
3National Cancer Center Hospital 5-1-1, Tsukiji, Chuo-ku, Tokyo Japan
4Department of Diagnostic Radiology Kangawa Cancer Center Hospital 2-3-2, Nakao, 18 Asahi-ku, Yokohama Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

491

Objectives: Boron neutron capture therapy (BNCT) is effective for the treatment of radioresistant tumors. In clinical BNCT, the tumor-to-normal tissue ratio (TNR) calculated from 18F-BPA PET images at 1 h after administration has been used for selecting patients. We previously demonstrated that dynamic SUVmax curves of 18F-BPA in unresectable tumors from 30 to 120 min showed different patterns (Morita et al., Radiation Oncology 2018, SNMMI 2018 and 2019 abstracts). In this study, we evaluated dynamic SUVmax and TNR of 18F-BPA uptake in the squamous cell head and neck cancer (SCC) and soft tissue sarcoma (STS) from 30 to 120 min.

Methods: Our study included 20 cases of SCC and 19 cases of STS. The two parameters for 18F-BPA were obtained at 30, 60 and 120mins, The data were performed using one-way ANOVA and the paired t-test was employed.

Results: The patient characteristics and the 18F-BPA PET values are shown in Table 1. SUVmax of SCC and STS showed a gradual decrease, but the decrease was statistically significant only between 30 and 120 min. No significant TNR changes of 18F-FBPA were seen in SCC and STS.

Conclusions: SUVmax of 18F-BPA in SCC and STS showed significant differences between 30 and 120 min, while the TNR of SCC and STS showed no significant changes. Dynamic SUVmax and TNR of 18F-BPA uptake may show different changes in certain types of cancer. 18F-BPA TNR should be carefully interpreted to identify appropriate BNCT patients and improve the BNCT treatment.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dynamic differences between SUVmax and tumor to normal tissue ratio of 18F-BPA PET in radioresistant squamous cell head and neck cancer and soft tissue sarcoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dynamic differences between SUVmax and tumor to normal tissue ratio of 18F-BPA PET in radioresistant squamous cell head and neck cancer and soft tissue sarcoma
Takahiro Morita, Jun Hatazawa, Hiroaki Kurihara
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 491;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dynamic differences between SUVmax and tumor to normal tissue ratio of 18F-BPA PET in radioresistant squamous cell head and neck cancer and soft tissue sarcoma
Takahiro Morita, Jun Hatazawa, Hiroaki Kurihara
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 491;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Assessment of incidental pituitary uptake on FDG PET/CT scan: Digital vs. conventional PET/CT
  • Thyroglobulin measurement in fine-needle aspiration optimize lateral neck dissection in patients with papillary thyroid cancer
Show more Oncology: Clinical Therapy and Diagnosis

Sarcoma, Melanoma & Others

  • Role of 18F-FDG PET/CT Imaging in Cardiac Masses
  • Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy
  • 18F-FDG PET/CT in prognostication of malignant peripheral nerve sheath tumors.
Show more Sarcoma, Melanoma & Others

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire